While multiple independent studies have identified FOXM1 upregulation in aggressive and proliferative meningiomas,3,30–32 no significant difference in expression of FOXM1 or its gene targets was identified in recurrent vs. non-recurrent tumors in our cohort. The gene discussed is FOXM1; the disease is meningioma.